Aspire Biopharma Holdings, Inc.
ASBP
$0.3366
-$0.0277-7.60%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -84.69% | 37,302.78% | -78.18% | -15.82% | 75.00% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 26.53% | 328.67% | -13.79% | 458.33% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -49.66% | 1,228.04% | -19.57% | 270.97% | -- |
|
|
|||||
| Total Current Assets | -49.66% | 1,228.04% | -19.57% | 270.97% | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -49.66% | 1,228.04% | -19.57% | -96.36% | -- |
|
|
|||||
| Total Accounts Payable | -5.61% | 361.64% | 139.72% | -19.88% | -- |
| Total Accrued Expenses | 8.80% | -- | -- | -- | -- |
| Short-term Debt | 25.27% | 433.96% | 48.49% | 91.54% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 3,480.65% | -98.03% | -- |
| Total Other Current Liabilities | -- | -- | 3,480.65% | -98.03% | -- |
| Total Current Liabilities | 19.03% | 425.38% | 71.28% | 28.95% | -- |
|
|
|||||
| Total Current Liabilities | 19.03% | 425.38% | 71.28% | 28.95% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 25.27% | 433.96% | 48.49% | 91.54% | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | -- | -- | -- | -- |
| Total Liabilities | 18.93% | 428.30% | 71.28% | -78.65% | -- |
|
|
|||||
| Common Stock & APIC | -5.80% | 851.08% | 0.00% | -44.70% | -- |
| Retained Earnings | -10.58% | -574.01% | -36.22% | -13.57% | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -38.32% | -351.44% | -92.13% | -281.36% | 190.59% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -38.32% | -351.44% | -92.13% | -281.36% | 190.59% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -38.32% | -351.44% | -92.13% | -281.36% | 190.59% |
|
|
|||||